Ionis Pharmaceuticals (IONS) Short Interest Ratio & Short Volume

Short interest is the volume of Ionis Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 7,110,000 shares of IONS short. 5.11% of Ionis Pharmaceuticals' shares are currently sold short. Learn More on Ionis Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IONS shares currently have a short interest ratio of 7.0. Learn More on Ionis Pharmaceuticals's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ionis Pharmaceuticals: Susquehanna International Group LLP, Jane Street Group LLC, Boothbay Fund Management LLC, Group One Trading L.P., BNP Paribas Arbitrage SNC, Citigroup Inc., Wolverine Asset Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.11% of Ionis Pharmaceuticals' floating shares are currently sold short.

Ionis Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 7,110,000 shares, an increase of 1.3% from the previous total of 7,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Ionis Pharmaceuticals currently has issued a total of 143,100,000 shares. Some of Ionis Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ionis Pharmaceuticals currently has a public float of 139,170,000 shares.

5.11% of Ionis Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ionis Pharmaceuticals: Madrigal Pharmaceuticals, Inc. (9.01%), Alkermes plc (4.49%), Amicus Therapeutics, Inc. (7.53%), ImmunoGen, Inc. (6.89%), United Therapeutics Co. (2.86%), Geron Co. (4.54%), Ironwood Pharmaceuticals, Inc. (10.94%), BioMarin Pharmaceutical Inc. (3.73%), Intra-Cellular Therapies, Inc. (3.71%), Grifols, S.A. (2.24%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

Short selling IONS is an investing strategy that aims to generate trading profit from Ionis Pharmaceuticals as its price is falling. IONS shares are trading down $1.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ionis Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IONS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IONS, twice per month. The most recent reporting period available is May, 15 2023.